What is William Blair’s Forecast for GE Vernova Q1 Earnings?
Stock analysts at William Blair dropped their Q1 2025 earnings per share estimates for GE Vernova in a research report issued ...
FierceBiotech2h
CROs should brace for continued slow Big Pharma R&D spending: analyst
Demand slipped for several large contract research organizations last year, and a new report from William Blair analysts suggests these firms should brace for a similar R&D landscape in 2025.
GE Vernova Stock Had Its Worst Day Ever. Wall Street Sees a Rebound Coming.
Shares of the power-generation-tech firm tumbled Monday as investors were unnerved by DeepSeek, an unexpectedly good Chinese ...
Hosted on MSN2h
Sage rejects Biogen’s $469m takeover bid
Sage’s board of directors said that the proposal “significantly undervalues” the company and is not in the best interest of ...
FY2024 EPS Estimate for Palantir Technologies Cut by Analyst
Stock analysts at Wedbush decreased their FY2024 earnings estimates for shares of Palantir Technologies in a research report issued to clients and investors on Wednesday, January 22nd. Wedbush analyst ...